Bradford J. Shafer, EVP, General Counsel, Secretary at Theravance Biopharma, Inc. (TBPH), sold 53,130 shares at $28.55 ($1.5M) on 2016-08-18, disclosed to the SEC on 2016-08-22.
Open-market sale of $1.5M TBPH by EVP, General Counsel, Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.55 | 7,174 | $205K | 14.0% |
| 2 | $28.14 | 4,870 | $137K | 9.4% |
| 3 | $27.89 | 4,008 | $112K | 7.7% |
| 4 | $27.16 | 37,078 | $1.0M | 68.9% |
| Total | $27.49 avg | 53,130 | $1.5M | 100% |
| Filing → |
| TBPH | SELL | 2018-06-08 | $581K | — | Filing → |
| TBPH | SELL | 2017-09-08 | $903K | — | Filing → |
| TBPH | SELL | 2017-03-07 | $1.7M | — | Filing → |